May 07, 2019 / 09:00PM GMT
Operator
Good afternoon, and welcome to Editas Medicine's First Quarter 2019 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Mark Mullikin, Vice President of Finance and Investor Relations at Editas Medicine.
Mark J. Mullikin - Editas Medicine, Inc. - Senior Director of Finance & IR
Thank you, operator. Good afternoon, everyone, and welcome to our first quarter 2019 conference call. Shortly after the market closed, we issued a press release providing our financial results and corporate updates for the first quarter of 2019. A replay of today's call will be available on the Investors and Media section of our website approximately 2 hours after its completion. After our prepared remarks, we will open the call for Q&A. As a reminder, various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities
Q1 2019 Editas Medicine Inc Earnings Call Transcript
May 08, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers